Semaglutide-a new treatment for obesity-related heart failure with preserved ejection fraction? Donal E, L'Official G, Istratoaie S. Lancet 2024 Apr 4:S0140-6736(24)00653-6. doi: 10.1016/S0140-6736(24)00653.

Read + Share

Amedeo Smart

Independent Medical Education

Donal E, L'Official G, Istratoaie S. Semaglutide-a new treatment for obesity-related heart failure with preserved ejection fraction? Lancet 2024 Apr 4:S0140-6736(24)00653-6. doi: 10.1016/S0140-6736(24)00653.
PMID: 38599218